Riskpilot← Back to searchSign inGet full accessEst Medical AB
ABActiveOrg 5591473656Tengvallsgatan 29Wholesale of pharmaceutical and medical goods · NACE 4646Est. 20180 employees
Revenue 2025
SEK 0
EBITDA margin
—
Equity ratio
1.1%
Financial strength
Net profit 2025
SEK -33K
+41% vs 2024
| Revenue | SEK 0 | — |
| EBITDA | — | — |
| Net profit | SEK -33K | +41% |
| Total assets | SEK 481K | -37% |
| Equity | SEK 5K | -86% |
| Employees | 0 | — |
Legal name
Est Medical AB
Org number
5591473656
Legal form
Aktiebolag
NACE code
4646 · Wholesale of pharmaceutical and medical goods
Founded
31 januari 2018
Share capital
SEK 50 000
Employees
0
VAT registered
Yes
Audit selected
No
Last report
2025-12-31
Financial year
January – December
Signatory rights
Firman tecknas ensam av Schiöld, Anders Ingemar Johan
Company purpose
Föremålet för bolagets verksamhet är att bedriva försäljning av sjukvårdsartiklar samt äga och förvalta aktier och andra värdepapper och därmed förenlig verksamhet.
Address
Tengvallsgatan 29
Email
anders.schiold66@gmail.com
Risika for professionals
Risika provides regulated workflow tools for finance, procurement and compliance teams that need monitoring, alerts and an API.
| Item | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|
| Revenue | 358 | 3 748 | 334 | −0 | 0 |
| Staff expenses | — | −9 | −0 | — | −0 |
| EBITDA | −20 | 375 | −208 | −22 | — |
| Depreciation & amort. | −0 | −3 | −26 | — | — |
| EBIT | −20 | 371 | −235 | −22 | 0 |
| Net financials | −18 | −38 | −30 | −34 | −33 |
| Profit before tax | −38 | 334 | −265 | −56 | −33 |
| Tax | −0 | — | — | — | — |
| Net profit | −38 | 334 | −265 | −56 | −33 |
| Item | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|
| Total assets | 559 | 886 | 762 | 762 | 481 |
| Equity | 25 | 359 | 94 | 38 | 5 |
| Long-term debt | 147 | 387 | 522 | 653 | 476 |
| Short-term debt | 387 | 141 | 146 | 71 | 0 |
| Total debt | 534 | 528 | 668 | 724 | 476 |
EBITDA margin
0.0%
This company
15.8%
Market median
-100% vs market
20212025
Equity ratio
1.1%
This company
38.2%
Market median
-97% vs market
20212025
Return on equity
-631.5%
This company
18.4%
Market median
-3532% vs market
20212025
Net profit margin
-3282300.0%
This company
8.1%
Market median
-40522322% vs market
20212025
Asset turnover
0.00×
This company
1.12×
Market median
-100% vs market
20212025
Debt / equity
91.49×
This company
0.62×
Market median
-14656% vs market
20212025
- Annual report 2025Filed via Bolagsverket / SCB · Period 2025-01-01 – 2025-12-31
- Annual report 2024Filed via Bolagsverket / SCB · Period 2024-01-01 – 2024-12-31
- Annual report 2023Filed via Bolagsverket / SCB · Period 2023-01-01 – 2023-12-31
- Annual report 2022Filed via Bolagsverket / SCB · Period 2022-01-01 – 2022-12-31
- Annual report 2021Filed via Bolagsverket / SCB · Period 2021-01-01 – 2021-12-31
| Name | Role | Member since |
|---|---|---|
| Current (1) | ||
AI Chief Executive Officer | Chief Executive Officer | 2026 |
| Former (1) | ||
TV External Signatory | External Signatory | 2021 – 2022 |
| Name | Role | Member since |
|---|---|---|
| Current (1) | ||
| Deputy Board Member | 2026 | |
| Former (1) | ||
| Deputy Board Member | 2022 – 2026 | |
No shareholder data available.
Beneficial ownership (UBO) data access is restricted in Denmark as of September 2025 per the EU 6th AML Directive. Learn more.
No registered parent or subsidiaries
Board members of Est Medical AB also hold positions in 0 other companies.
| Person | Role here | Other companies |
|---|---|---|
| Tony Valdemar Rydberg | External Signatory | 0 companies |
| Anders Ingemar Johan Schiöld | Chief Executive Officer | 0 companies |
| Malin Margareta Emblad | Deputy Board Member | 0 companies |
| Linda Charlotte Ander | Deputy Board Member | 0 companies |